| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.85▲ | 1.85▲ | 1.84▲ | 1.74▲ | 1.80▲ |
| MA10 | 1.84▲ | 1.83▲ | 1.82▲ | 1.74▲ | 1.80▲ |
| MA20 | 1.82▲ | 1.81▲ | 1.75▲ | 1.80▲ | 1.87▼ |
| MA50 | 1.81▲ | 1.73▲ | 1.72▲ | 1.78▲ | 2.14▼ |
| MA100 | 1.75▲ | 1.73▲ | 1.78▲ | 1.95▼ | 2.03▼ |
| MA200 | 1.71▲ | 1.80▲ | 1.80▲ | 2.20▼ | 2.73▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.002▲ | 0.012▲ | 0.000▲ | 0.006▲ |
| RSI | 62.598▲ | 68.474▲ | 66.121▲ | 53.827▲ | 47.649▼ |
| STOCH | 85.952▲ | 89.369▲ | 90.590▲ | 46.069 | 42.236 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -43.182 | -56.338 |
| CCI | 105.000▲ | 113.401▲ | 84.651 | 63.989 | -41.135 |
| ▲ MACD | $GANX MACD(12,26,9) Crossed Above Signal Line | Set Alert |
|
Saturday, July 18, 2026 02:38 AM
Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, July 16, 2026 04:01 AM
Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
|
|
Thursday, June 11, 2026 12:58 PM
Gain Therapeutics, Inc. (Nasdaq: GANX) today announced the appointment of C. Evan Ballantyne as the Company’s Chief Financial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/07/26 | 1.82 | 1.87 | 1.79 | 1.84 | 370,390 |
| 21/07/26 | 1.65 | 1.85 | 1.63 | 1.84 | 682,763 |
| 20/07/26 | 1.74 | 1.75 | 1.625 | 1.63 | 339,977 |
| 17/07/26 | 1.65 | 1.72 | 1.60 | 1.71 | 503,233 |
| 16/07/26 | 1.69 | 1.70 | 1.625 | 1.66 | 845,830 |
| 15/07/26 | 1.69 | 1.70 | 1.59 | 1.68 | 995,530 |
| 14/07/26 | 1.78 | 1.855 | 1.67 | 1.68 | 1,468,565 |
| 13/07/26 | 1.79 | 1.85 | 1.74 | 1.76 | 997,398 |
| 10/07/26 | 1.82 | 1.82 | 1.74 | 1.80 | 610,322 |
| 09/07/26 | 1.82 | 1.87 | 1.79 | 1.82 | 589,393 |
|
|
||||
|
|
||||
|
|